Appearance

Active: dark

Light warmth: 0%0 = neutral light, 100 = warm sepia light.Dark depth: 0%0 = neutral dark, 100 = midnight black.

Accent

Custom

Corner radius

Font

Layout

Sidebar width: 224pxChat width: 50%

Data refresh

Auto-ingest on app launchAuto-ingest source

Runs once per app session in the background and keeps existing data if source APIs are unavailable.

Annotation style

HighlightStrike

User/group key (shared note namespace)

Ask · OpenAI

Refine NL queries with model

Requires OPENAI_API_KEY on the server. Heuristics always run first.

← Disease database

metabolic dysfunction and alcohol associated liver disease

A steatotic liver disease characterized by at least one of the five cardiometabolic risk factors for MASLD and alcohol consumption of 140-350g/week (females) or 210-420g/week (males). This disease is distinguished from MASLD by increased alcohol consumption and from ALD by the evidence of one or more of the MASLD cardiometabolic risk factors.

Therapeutic area: Gastroenterology · Endocrine / Metabolic
Rarity: Unknown
Prevalence: —
MONDO: MONDO:0957896

Overview

A steatotic liver disease characterized by at least one of the five cardiometabolic risk factors for MASLD and alcohol consumption of 140-350g/week (females) or 210-420g/week (males). This disease is distinguished from MASLD by increased alcohol consumption and from ALD by the evidence of one or more of the MASLD cardiometabolic risk factors.

Content last reviewed: 2026-06